Treatment Outcomes and Predictors Among Tuberculosis Patients at Madda Walabu University Goba Referral Hospital, Southeast Ethiopia

Figures & data

Table 1 Baseline Characteristics of the Study Participants Attending the TB Clinic of Madda Walabu University Goba Referral Hospital from January, 2015 to December, 2019

Variables	Category	Frequency (n)	Proportion (%)
Sex	Male	218	58.4
	Female	155	41.6
Age category	<18	56	15.0
	18–25	87	23.3
	25–35	94	25.2
	35–50	78	20.9
	>50	58	15.5
Weight category at start of treatment	<20	83	22.3
	20–30	122	32.7
	30–45	89	23.9
	>45	79	21.2
Address	Urban	323	86.6
	Rural	50	13.4
Year of treatment	2015	75	20.1
	2016	79	21.2
	2017	71	19.0
	2018	76	20.4
	2019	72	19.3

Table 2 TB Disease-Related Characteristics of the Study Participants Attending the TB Clinic of Madda Walabu University Goba Referral Hospital from January, 2015 to December, 2019

Variables	Category	Frequency (n)	Proportion (%)
Type of TB	PTB	205	55.0
	EPTB	168	45.0
Smear result	Smear positive	142	38.1
	Smear negative	228	61.1
	Unknown	3	0.8
HIV status	HIV-positive	65	17.4
	HIV-negative	296	79.4
	Unknown	12	3.2
Cotrimoxazole reventive herapy initiated	Yes	64	17.2
	No	251	67.3
	Unknown	58	15.5
Smear result after 2 months	Smear positive	17	4.6
	Smear negative	267	71.6
	Unknown	89	23.9
Anti-TB drug on Intensive phase	RHZE	365	97.9
	RHZES	8	2.1
Anti-TB drug on continuation phase	RH	357	95.7
	EH	16	4.3

Abbreviations: PTB, pulmonary TB; RHZE, rifampicin, isoniazide, pyrazinamide, ethambutol; RHZES, rifampicin, isoniazide, pyrazinamide, ethambutol, streptomycin; RH, rifampicin, isoniazide; EH, ethambutol, isoniazide.

Table 3 TB Treatment Outcomes-Related Characteristics of the Study Participants Attending the TB Clinic of Madda Walabu University Goba Referral Hospital from January, 2015 to December, 2019

Treatment Outcomes	Category	Frequency (n)	Percentage %
Successful outcomes	Cured	91	25.9
	Completed	229	65.2
	Died	18	5.1
	Failure	3	0.9
Unsuccessful outcomes	Moved to MDR-TB	6	1.7
	Lost to follow-up	4	1.1
Unknown final status	Transfer out	12	3.2
	Not evaluated	10	2.7
Overall success rate	Successful	320	91.2 [95% CI, 88–94.3]
	Unsuccessful	31	8.8 [95% CI, 5.7–12]

Abbreviation: CI, confidence interval.

Table 4 Multiple Logistic Regression of Predictors with TB Treatment Outcomes Among the Study Participants Attending the TB Clinic of Madda Walabu University Goba Referral Hospital from January, 2015 to December, 2019

Variables	Category	COR (95% CI)	P value	AOR (95% CI)	P value
Age	Age < 25		1.000		1.000
	25–40	1.3 (0.4–3.7)	0.614	0.8 (0.2–2.6)	0.825
	> 40	3.4 (1.3–8.6)	0.009*	3.1 (1.1–8.1)	0.021**
Year of treatment	2015	0.8 (0.2–2.8)	0.753	0.7 (0.1–2.6)	0.630
	2016	1.2 (0.4–3.8)	0.654	1.1 (0.3–3.5)	0.821
	2017	1.4 (0.4–4.2)	0.523	1.1 (0.3–3.6)	0.827
	2018	0.2 (0.0–1.4)	0.129	0.2 (0.1–1.5)	0.146
	2019		1.000		1.000
HIV status	HIV-positive	4.8 (2.2–10.6)	0.000*	4.9 (2.01–11.5)	0.000**
	Unknown	1.4 (0.1–12.2)	0.711	1.4 (0.1–12.8)	0.757
	HIV-negative		1.000		1.000

Notes: *Statically significant in bivariate; **statistically significant in multivariate.

Abbreviations: AOR, adjusted odds ratio; CI, confidence interval; COR, crude odds ratio; HIV, human immunodeficiency virus.